Timothy C. Barabe, a director at Cartesian Therapeutics, Inc. ($RNAC), made one open market purchase of common shares in the last 365 days, totaling about $206 thousand. His most recent buy occurred on December 4, 2025. Among 4,983 insiders with purchases, his amount ranks 1,511th, below the average of $1.5 million across about 3.3 transactions per insider. Barabe reported no open market sales in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | Heartflow, Inc. | $HTFL | BARABE TIMOTHY C | Director | M | Stock Option | 8667 | $0.00 | 15,412.0000 | 85,158,719 | 35.99% | 0.01% |
| March 11, 2026 | Heartflow, Inc. | $HTFL | BARABE TIMOTHY C | Director | M | Common Stock | 8667 | $2.22 | 179,521.0000 | 85,158,719 | 5.07% | 0.01% |
| Feb. 17, 2026 | Heartflow, Inc. | $HTFL | BARABE TIMOTHY C | Director | M | Stock Option | 2497 | $0.00 | 0.0000 | 85,158,719 | 100.00% | 0.00% |
| Feb. 17, 2026 | Heartflow, Inc. | $HTFL | BARABE TIMOTHY C | Director | M | Common Stock | 2497 | $8.33 | 170,854.0000 | 85,158,719 | 1.48% | 0.00% |
| Jan. 2, 2026 | Cartesian Therapeutics, Inc. | $RNAC | BARABE TIMOTHY C | Director | A | Common Stock | 2600 | $0.00 | 56,966.0000 | 26,003,606 | 4.78% | 0.01% |
| Jan. 2, 2026 | Cartesian Therapeutics, Inc. | $RNAC | BARABE TIMOTHY C | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 26,003,606 | 9999.99% | 0.03% |
| Dec. 4, 2025 | Cartesian Therapeutics, Inc. | $RNAC | BARABE TIMOTHY C | Director | P | Common Stock | 30000 | $6.86 | 54,366.0000 | 26,003,606 | 123.12% | 0.12% |
| Aug. 7, 2025 | Heartflow, Inc. | $HTFL | BARABE TIMOTHY C | Director | A | Stock Option | 23710 | $0.00 | 23,710.0000 | 0 | 9999.99% | 0.00% |
| Aug. 11, 2025 | Heartflow, Inc. | $HTFL | BARABE TIMOTHY C | Director | C | Convertible Promissory Note | 131578 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 11, 2025 | Heartflow, Inc. | $HTFL | BARABE TIMOTHY C | Director | C | Common Stock | 131578 | $0.00 | 168,357.0000 | 0 | 357.75% | 0.00% |
| Jan. 2, 2025 | Cartesian Therapeutics, Inc. | $RNAC | BARABE TIMOTHY C | Director | A | Common Stock | 2600 | $0.00 | 24,366.0000 | 25,767,369 | 11.95% | 0.01% |
| Jan. 2, 2025 | Cartesian Therapeutics, Inc. | $RNAC | BARABE TIMOTHY C | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 25,767,369 | 9999.99% | 0.03% |
| Aug. 12, 2024 | Cartesian Therapeutics, Inc. | $RNAC | BARABE TIMOTHY C | Director | P | Common Stock | 7500 | $12.70 | 21,766.0000 | 17,816,238 | 52.57% | 0.04% |
| Jan. 2, 2024 | Cartesian Therapeutics, Inc. | $RNAC | BARABE TIMOTHY C | Director | A | Stock Option (Right to Buy) | 228000 | $0.00 | 228,000.0000 | 5,397,597 | 9999.99% | 4.22% |
| Jan. 2, 2024 | Cartesian Therapeutics, Inc. | $RNAC | BARABE TIMOTHY C | Director | A | Common Stock | 178000 | $0.00 | 428,013.0000 | 5,397,597 | 71.20% | 3.30% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | BARABE TIMOTHY C | Director | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.39% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | BARABE TIMOTHY C | Director | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.78% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | BARABE TIMOTHY C | Director | D | Stock Option (Right to Buy) | 6410 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.13% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | BARABE TIMOTHY C | Director | D | Stock Option (Right to Buy) | 10328 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.20% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | BARABE TIMOTHY C | Director | D | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.20% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | BARABE TIMOTHY C | Director | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 5,101,459 | 100.00% | 0.78% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | BARABE TIMOTHY C | Director | D | Stock Option (Right to Buy) | 87500 | $0.93 | 0.0000 | 5,101,459 | 100.00% | 1.72% |
| Jan. 2, 2023 | Cartesian Therapeutics, Inc. | $RNAC | BARABE TIMOTHY C | Director | A | Stock Option (Right to Buy) | 87500 | $0.00 | 87,500.0000 | 5,101,459 | 9999.99% | 1.72% |